Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine (Q34550453)

3 August 2017

title

Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine (English)

1 reference

seasonal allergic rhinitis

3 August 2017

1 reference

1 reference

1 reference

2

Jonathan Corren

1 reference

3 August 2017

Craig F LaForce

1

1 reference

3 August 2017

William J Wheeler

series ordinal

3

1 reference

3 August 2017

William E Berger

series ordinal

4

1 reference

3 August 2017

Rhinitis Study Group

series ordinal

5

1 reference

3 August 2017

publication date

1 August 2004

1 reference

Annals of Allergy, Asthma & Immunology

3 August 2017

published in

1 reference

3 August 2017

volume

93

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

154-159

1 reference

Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

How many teenagers think they have allergic rhinoconjunctivitis and what they do about it.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Clinical advantages of dual activity in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Inhibition of allergic and nonallergic leukotriene C4 formation and histamine secretion by azelastine: implication for its mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Inhibition of leukotriene synthesis by azelastine

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

The effect of azelastine on the early allergic response

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Contrasting influence of peplomycin and azelastine hydrochloride (Azeptin) on reactive oxygen generation in polymorphonuclear leukocytes, cytokine generation in lymphocytes, and collagen synthesis in fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Antihistamines: topical vs oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

Effect of topical applications of budesonide and azelastine on nasal symptoms, eosinophil count and mediator release in atopic patients after nasal allergen challenge during the pollen season

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961468-8

7 January 2021

10.1016/S1081-1206(10)61468-8

Identifiers

DOI

1 reference

3 August 2017

1 reference